Omecamtiv Mecarbil - Is It More Effective in Low EFs

What is the Role of LVADs for BTR?

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Evidence for Revascularization in HFrEF Patients

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

How to Improve Diversity in Heart Failure: Patients, Investigators, Trials

Disparities in Access to Technology

Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting?

SGLT2 Inhibitors in HFrEF and HFpEF

SGLT2 Inhibitors: What the Clinician Should Know